Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Adjuvant Treatment of BRAF V600-Mutant Melanoma
.
Show all posts
Showing posts with label
Adjuvant Treatment of BRAF V600-Mutant Melanoma
.
Show all posts
Friday, May 18, 2018
Novartis Receives FDA Approval of Tafinlar + Mekinist for Adjuvant Treatment of BRAF V600-Mutant Melanoma
›
Novartis announced that the US Food and Drug Administration (FDA) has approved Tafinlar ® ( dabrafenib ) in combination with Mekinist ...
›
Home
View web version
